These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10544869)

  • 21. Atypical neuroleptic malignant syndrome caused by clozapine and venlafaxine: early brief treatment with dantrolene.
    Ferioli V; Manes A; Melloni C; Nanni S; Boncompagni G
    Can J Psychiatry; 2004 Jul; 49(7):497-8. PubMed ID: 15362259
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuroleptic malignant syndrome.
    Martin ML; Lucid EJ; Walker RW
    Ann Emerg Med; 1985 Apr; 14(4):354-8. PubMed ID: 3985449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neuroleptic malignant syndrome: agent and host interaction.
    Shalev A; Munitz H
    Acta Psychiatr Scand; 1986 Apr; 73(4):337-47. PubMed ID: 2873715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
    Khan A; Jaffe JH; Nelson WH; Morrison B
    J Clin Psychiatry; 1985 Jun; 46(6):244-6. PubMed ID: 3922961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent fever in a case of typhoid--an unusual cause of neuroleptic malignant syndrome.
    Yeolekar ME; Gupta H
    J Assoc Physicians India; 2001 Feb; 49():296. PubMed ID: 11225156
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndrome.
    Nisijima K; Noguti M; Ishiguro T
    Biol Psychiatry; 1997 Apr; 41(8):913-4. PubMed ID: 9099421
    [No Abstract]   [Full Text] [Related]  

  • 27. Exacerbating factors in neuroleptic malignant syndrome: comparisons between cases with death, sequelae, and full recovery.
    Nagamine M; Yoshino A; Sakurai Y; Sanga M; Takahashi R; Nomura S
    J Clin Psychopharmacol; 2005 Oct; 25(5):499-501. PubMed ID: 16160631
    [No Abstract]   [Full Text] [Related]  

  • 28. [Acute renal failure in neuroleptic malignant syndrome].
    Wagner G; Rónai L
    Orv Hetil; 1995 Oct; 136(40):2173-6. PubMed ID: 7566952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical aspects, pathogenesis and treatment of neuroleptic malignant syndrome].
    Sep-Kowalikowa B
    Psychiatr Pol; 1989; 23(1):44-53. PubMed ID: 2573100
    [No Abstract]   [Full Text] [Related]  

  • 30. The neuroleptic malignant syndrome: occurrence in a 15-year-old boy and recovery with bromocriptine therapy.
    Tenenbein M
    Pediatr Neurosci; 1985-1986; 12(3):161-4. PubMed ID: 3870437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuroleptic malignant syndrome-dopamine-serotonin syndrome--the physiopathology, diagnosis, and therapy].
    Naito Y
    Seishin Shinkeigaku Zasshi; 1997; 99(10):803-8. PubMed ID: 9465737
    [No Abstract]   [Full Text] [Related]  

  • 32. Possible central effect of dantrolene sodium in neuroleptic malignant syndrome.
    Yamawaki S; Yanagawa K; Morio M; Mori K
    J Clin Psychopharmacol; 1986 Dec; 6(6):378-9. PubMed ID: 3805336
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroleptic malignant syndrome associated with metoclopramide in a burn patient.
    Nachreiner R; Balledux J; Zieger M; Viegas O; Sood R
    J Burn Care Res; 2006; 27(2):237-41. PubMed ID: 16566575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome with hypotonia: a diagnostic challenge.
    Korn-Lubetzki I; Gottlieb S
    Eur Neurol; 2001; 46(1):50-1. PubMed ID: 11455185
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neuroleptic malignant syndrome].
    Usandizaga I; Pérez de Mendiola MM; Buades J; Martínez J
    Med Clin (Barc); 1990 Oct; 95(11):437. PubMed ID: 2082117
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant.
    Baca L; Martinelli L
    Neurology; 1990 Nov; 40(11):1797-8. PubMed ID: 2234440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic malignant syndrome.
    Nicholson D; Chiu W
    Geriatrics; 2004 Aug; 59(8):36, 38-40. PubMed ID: 15332415
    [No Abstract]   [Full Text] [Related]  

  • 38. [Extrapyramidal reactions and neuroleptic malignant syndrome].
    Gómez EA
    Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):281-6. PubMed ID: 6535382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catatonia and neuroleptic malignant syndrome: two sides of a coin?
    Vancaester E; Santens P
    Acta Neurol Belg; 2007 Jun; 107(2):47-50. PubMed ID: 17710840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality from neuroleptic malignant syndrome.
    Shalev A; Hermesh H; Munitz H
    J Clin Psychiatry; 1989 Jan; 50(1):18-25. PubMed ID: 2562951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.